Skip to main content
COCH logo

Envoy Medical, Inc.

COCHNASDAQHealthcareMedical Devices

$0.60Today:- (-)1Y −27.55%

As of Oct 22, 2026 close

Market cap
$62.00M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.36$0.95
Volume (live)
-
Avg. volume (3M)
76.96K

Envoy Medical (COCH) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Envoy Medical used $18.20M of cash in operating activities and spent $179.00K on capital expenditures. That left free cash flow of −$18.38M. It paid $1.82M in dividends.

Envoy Medical Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Envoy Medical, Inc. (COCH) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2021
Period endingDec 2025Mar 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-23.76-22.45-20.80-29.92-29.92-15.92-0.25
Depreciation & Amortization0.300.170.170.130.130.080.07
Stock Based Compensation0.750.000.561.581.580.000.00
Change in Working Capital1.84-0.64-0.64-0.98-0.98-0.16-0.08
Change in Accounts Receivable0.77-0.57-0.57-0.21-0.210.05-0.02
Change in Inventory0.13-0.38-0.38-0.01-0.01-0.190.06
Change in Accounts Payable1.39-0.02-0.020.550.550.340.23
Change in Other Working Capital-1.120.331.98-1.32-0.98-0.361.75
Other Operating Activities2.674.971.9812.1112.117.201.75
Net Cash from Operating Activities-18.20-17.95-17.95-17.09-17.09-8.81-6.94
Investing Activities
Capital Expenditures-0.18-0.98-0.98-0.15-0.15-0.22-0.13
Other Investing Activities0.000.00-0.00-0.00-425.00
Net Cash from Investing Activities-0.18-0.98-0.98-0.15-0.15-0.22-0.13
Financing Activities
Debt Repayment-0.9319.08-0.929.44-0.568.008.00
Common Stock Issued7.103.561.750.1111.850.09425.00
Dividends Paid-1.82-2.45-2.450.00-0.000.00
Other Financing Activities2.280.00-0.9211.7411.740.000.06
Net Cash from Financing Activities16.6320.2020.2021.2821.288.098.06
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.96-0.01
Net Change in Cash-1.741.271.264.044.040.031.00
Cash at Beginning of Period5.484.224.220.180.180.150.13
Cash at End of Period3.745.485.484.224.220.181.12
Free Cash Flow-18.38-18.93-18.93-17.24-17.24-9.02-7.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Envoy Medical Cash Flow

What is Envoy Medical's free cash flow?

Envoy Medical had negative free cash flow of $18.38M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$18.20M minus $179.00K of capital expenditures.

How much does Envoy Medical spend on capital expenditures?

Envoy Medical spent $179.00K on capital expenditures in fiscal 2025, compared with $980.00K a year earlier.

Does Envoy Medical pay dividends or buy back shares?

Yes. In fiscal 2025 Envoy Medical returned $1.82M in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition